Miglustat Dipharma 100 mg

Miglustat Dipharma 100 mg is a medicine authorised by Swissmedic under authorisation number 67633. The authorisation holder is Dipharma SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 April 2020 and the authorisation is valid without a time limit. ATC code A16AX06 places the medicine in the group Other alimentary tract and metabolism products.

  • Dispensing category B
  • Authorisation number 67633
  • ATC A16AX06
  • Synthetic medicines
Authorisation data
Authorisation number67633
NameMiglustat Dipharma 100 mg
Full nameMiglustat Dipharma 100 mg, capsule
Authorisation holderDipharma SA
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeA16AX06
First authorisation03 April 2020
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Miglustat Dipharma 100 mg, capsuleB03 April 2020

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
284Kapsel(n)A16AX0607.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Miglustat Dipharma 100 mg authorised in Switzerland?

Yes. Miglustat Dipharma 100 mg is authorised by Swissmedic under authorisation number 67633, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Miglustat Dipharma 100 mg have?

Miglustat Dipharma 100 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Miglustat Dipharma 100 mg?

The authorisation holder is Dipharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com